Inactive Instrument

Hospira, Inc. Share Price

Stocks

US4410601003

Pharmaceuticals

End-of-day quote NYSE
- ^USD	-

04/15/04	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
28/15/28	Allergan : Mylan independence from Teva's embrace comes with a price	RE

Latest news: Hospira, Inc.

04/15/04	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
28/15/28	Allergan : Mylan independence from Teva's embrace comes with a price	RE
14/15/14	Hospira : Pfizer offers concessions in bid to win EU okay for Hospira deal	RE
03/15/03	Celltrion : Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount	RE
07/15/07	Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal	RE
14/15/14	AbbVie : Banks see talent flee amid healthcare M&A boom	RE
09/15/09	Actavis : Generic drugmaker Mylan offers $29 billion for Perrigo	RE
05/15/05	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
05/15/05	AbbVie : Biotech buys get pharma M&A off to flying start in 2015	RE
05/15/05	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
25/15/25	Celltrion : Biosimilar copies of blockbuster drug launch in major EU markets	RE
06/15/06	Pfizer : to buy Hospira for $15 billion to bolster hospital products	RE
06/15/06	Hospira : Pfizer's Hospira deal bets on price spike for specialty generics	RE

Press Releases: Hospira, Inc.

27/15/27	Hospira : Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™	PU
27/15/27	Hospira : Announces First Installation of Plum 360(TM) Infusion System With Hospira MedNet(TM)	PR
21/15/21	Hospira : Expert committee BACKS Hospira’s InflectraTM	PU
20/15/20	Hospira : Charleston Area Medical Center Integrates Smart Pump Technology to Advance Patient Safety	PR
20/15/20	Hospira : TGA Approves First mAb Biosimilar	PR

More press releases

News in other languages: Hospira, Inc.

28/15/28	Activision Blizzard et United Continental intègrent le S&P-500
24/15/24	Apple : Les valeurs à suivre à Wall Street
24/15/24	USA-Les valeurs à suivre à Wall Street
03/15/03	American : Les valeurs à suivre sur les marchés américains
03/15/03	USA-Les valeurs à suivre à Wall Street

Generic Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	+0.99%	+7.76%	+55.10%	+106.09%	1,11600Cr
	JOHNSON & JOHNSON	+1.25%	-1.89%	+33.52%	+62.83%	61TCr
	ABBVIE INC.	+0.51%	+3.50%	+26.13%	+94.35%	50TCr
	MERCK & CO., INC.	+1.16%	+0.91%	+75.08%	+41.09%	36TCr
	ROCHE HOLDING AG	-0.53%	+5.56%	+32.39%	+49.79%	37TCr
	NOVARTIS AG	-0.99%	+4.70%	+19.51%	+43.00%	29TCr
	ASTRAZENECA PLC	-2.09%	+3.95%	-0.65%	+13.67%	26TCr
	AMGEN INC.	+0.59%	+5.57%	+48.06%	+52.67%	23TCr
	GILEAD SCIENCES, INC.	-0.77%	+3.61%	+32.91%	+97.77%	20TCr
	Average	-0.02%	+5.27%	+35.78%	+62.36%	43.66TCr
	Weighted average by Cap.	+0.35%	+4.93%	+39.93%	+72.34%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!